InvestorWire NewsRoom

Article

DGE’s 2nd Clinical Trial Agreements Conference to Negotiate Budgetary Restraints, Reduce Risks, and More in an Evolving Landscape
August 30, 2021

DGE’s 2nd Clinical Trial Agreements Conference to Negotiate Budgetary Restraints, Reduce Risks, and More in an Evolving Landscape

Date: September 16-17, 2021

Online Livestream Event – Locations will vary

Dynamic Global Events (“DGE”) invites biopharma and medical device industry professionals to join them online September 16-17, 2021, for the 2nd Clinical Trial Agreements Conference. DGE’s first event was held online earlier this year and was focused greatly on the COVID-19 pandemic, the confidentiality of subject data, and the increased use of telemedicine, among other topics. The first event helped industry professionals determine what needed to be considered before entering into a clinical trial agreement.

This conference features a distinguished speaking faculty ready to offer the strategies and best practices to guide professionals through the negotiation process toward a successful clinical trial agreement result.

Featured speakers during the two-day conference on September 16-17 will include Jeff Odom, Manager, Global Clinical Trial Contracts, Trial Capabilities – Eli Lilly (NYSE: LLY); Donald Louis Joseph Campodonico, Clinical Trials Contracts Officer I – Stanford University School of Medicine; Tracie Carroll, Associate General Counsel – Turning Point Therapeutics (NASDAQ: TPTX); and many others. 

Each of these speakers will be covering a specific topic area including, but not limited to, the impact of new standard contractual clauses and GDPR, the role of CROs in a clinical trial contract process; the in-depth look at negotiations between sites and sponsors; telemedicine and the role it plays with remote trial agreements; and the global landscape for clinical trial agreements.  

The Scarritt Group Companies, a company that supports clinical trial solutions, is sponsoring the event. Some of the event partners for the 2nd Clinical Trial Agreements Conference include BioMed Wire, InvestorBrandNetwork, Pharma Marketing Network, MedTube, and many other industry-driven organizations.

Online registration for the event is being held by RegFox and can be completed online through DGE’s conference website. The event carried an early bird special (prior to 8/20/2021) ticket price of $996, and standard/on-demand ticket pricing is $1,196. Registration and log-in for the event will take place on September 16, between 8:30 am and 9:00 am EST. The Chairperson’s opening remarks will begin promptly at 9:00 am.

For more information, or to see a full list of keynote speakers and partners for the 2nd Clinical Trial Agreements Conference, please visit the event website

To purchase tickets and register for the event, visit https://ibn.fm/O7ryT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Recent Articles

Release Categories

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).